Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 27, 2025

AYS Developers batirá el récord Guinness del mundo por la mayor sesión de formación inmobiliaria
DUBÁI, Emiratos Árabes Unidos, May 27, 2025 (GLOBE NEWSWIRE) -- AYS Developers, en colaboración con el Dr. Nour El-Serougy e Innovation Experts Real Estate Institute, organizará un evento de formación histórico el 31 de mayo de 2025 en el centro de …

AYS Developers vise à battre un record mondial Guinness de la plus grande session de formation en immobilier
DUBAÏ, Émirats arabes unis, 27 mai 2025 (GLOBE NEWSWIRE) -- AYS Developers, en collaboration avec le Dr Nour El-Serougy et l’Innovation Experts Real Estate Institute, accueillera un événement de formation historique le 31 mai 2025 au Grand Hyatt Convention …

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collaboration builds on …

AYS Developers to Break Guinness World Record for Largest Real Estate Training Session
DUBAI, United Arab Emirates, May 27, 2025 (GLOBE NEWSWIRE) -- AYS Developers, in collaboration with Dr. Nour El-Serougy and the Innovation Experts Real Estate Institute, will host a landmark training event on 31 May 2025 at the Grand Hyatt Convention …

A AYS Developers planeja estabelecer o recorde mundial do Guinness para a maior sessão de treinamento no setor imobiliário
DUBAI, Emirados Árabes Unidos, May 27, 2025 (GLOBE NEWSWIRE) -- A AYS Developers, em parceria com o Dr. Nour El-Serougy e o instituto imobiliário Innovation Experts Real Estate Institute, vai organizar um evento de treinamento de referência no dia 31 de …

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis
Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK) No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs observed across SAD/MAD cohorts Management releases a “ …

Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives
RA'ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneering company in advanced respiratory support and diagnostic systems, today announced an evolution in its executive …

Breaking News: Rasool Rezvani (RZ) Named Among the Most Influential Crypto Figures of 2025
Dubai, UAE, May 27, 2025 (GLOBE NEWSWIRE) -- In a major recognition of global impact and innovation, Rasool Rezvani—widely known as RZ—has been officially named one of the Top Crypto Entrepreneurs of 2025, according to a recent report by International …

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025
CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced an upcoming presentation at the …

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the …

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
- Study will assess relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine candidate against an approved mRNA comparator at 12 months - SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) …

Reflect Scientific, Inc. Announces Strategic Cost-Cutting Initiative to Reduce SG&A Expenses by Up to 35% in 2025
OREM, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in cryogenic cooling technologies, today announced a comprehensive initiative to reduce Selling, General …

Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement
RIMOUSKI, Quebec, May 27, 2025 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA) (“Puma”), announces that its subsidiary, Murray Brook Minerals Inc. (“MBM” or “Murray Brooks Minerals”) has closed a non-brokered offering consisting of 4,400,000 flow- …

ORYZON to Provide Corporate Progress Updates at Several Events in May-June
Foro MedCap 2025 BIO International Convention 2025 Discovery and Development Europe 2025 MADRID and CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a …

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary
**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) …

Final Settlement of Computing Power Loss! KixaMiner Launches Intelligent Chain Scheduling System with Millisecond-Level Optimal Mining Protocol Switching
London, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- KixaMiner, a pioneer in global compliant cloud mining, announced a major upgrade to its core technical architecture today – the official launch of the "Intelligent Chain Scheduling System" (ICSS). By …

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
Cash runway extended into 2028; capital proceeds to fund operations through potential 2027 efficacy readout for LX2006 in Friedreich ataxia cardiomyopathy Financing led by Frazier Life Sciences and Janus Henderson Investors with participation from new and …

Nexxen Announced as a Preliminary Addition to the Russell 3000 Index
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has been named a …

American Tungsten Corp. Commences Mine Site Preparation and Exploration Work
Vancouver, BC, May 27, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that the Company has commenced construction and building work to support exploration …

Swvl Secures 3-Year Contract Worth Up to $4 Million with a Large Enterprise in Essential Services
Swvl secures a 3-year contract worth up to $4 million, which it expects will exceed $5.2 million by contract expiry, which extends a longstanding relationship for a total of six years with this renewal Swvl’s services extend to provide accessibility to …